Biocon Ltd (BIOS IN): Stake Sale in Subsidiary Is a Step in Right Direction
Biocon divested 5.4% stake in Syngene for INR12.2B to partly fund Viatris acquisition. Stake sell in Biocon Biologics and final decision on Viatris...
ECM Weekly (12th Sep 2022) - Onewo, CALB, YSB, Medanta, Beneunder, JMDC, SH Holdings, Indigo
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
NIFTY100 Index Rebalance Preview: Couple of Changes in August, Then 5 More in September
There are two index changes at the close on 5 August, then there should be 5 more at the close on 29 September. Passive funds will have over 4-5...
Biocon- Management Meet Update
We hosted the Biocon management at our Annual Investor Conference to discuss the company’s business outlook. The company has multiple opportunities...
Smartkarma Originals